JPMorgan Chase & Co’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Sell |
|
|||||
|
2025
Q1 | $143M | Buy |
|
|||||
|
2024
Q4 | $246M | Sell |
|
|||||
|
2024
Q3 | $275M | Buy |
|
|||||
|
2024
Q2 | $291M | Buy |
|
|||||
|
2024
Q1 | $237M | Buy |
|
|||||
|
2023
Q4 | $126M | Sell |
|
|||||
|
2023
Q3 | $559M | Buy |
|
|||||
|
2023
Q2 | $504M | Buy |
|
|||||
|
2023
Q1 | $510M | Buy |
|
|||||
|
2022
Q4 | $161M | Buy |
|
|||||
|
2022
Q3 | $79.7M | Sell |
|
|||||
|
2022
Q2 | $76.7M | Sell |
|
|||||
|
2022
Q1 | $85.2M | Buy |
|
|||||
|
2021
Q4 | $94.4M | Sell |
|
|||||
|
2021
Q3 | $140M | Buy |
|
|||||
|
2021
Q2 | $102M | Buy |
|
|||||
|
2021
Q1 | $56.2M | Sell |
|
|||||
|
2020
Q4 | $129M | Sell |
|
|||||
|
2020
Q3 | $159M | Sell |
|
|||||
|
2020
Q2 | $253M | Buy |
|
|||||
|
2020
Q1 | $112M | Buy |
|
|||||
|
2019
Q4 | $121M | Buy |
|
|||||
|
2019
Q3 | $7.79M | Buy |
|
|||||
|
2019
Q2 | $12.7M | Sell |
|
|||||
|
2019
Q1 | $25.6M | Buy |
|
|||||
|
2018
Q4 | $22.4M | Buy |
|
|||||
|
2018
Q3 | $13.9M | Sell |
|
|||||
|
2018
Q2 | $26.6M | Sell |
|
|||||
|
2018
Q1 | $52.5M | Buy |
|
|||||
|
2017
Q4 | $24.2M | Buy |
|
|||||
|
2017
Q3 | $15M | Buy |
|
|||||
|
2017
Q2 | $9.3M | Buy |
|
|||||
|
2017
Q1 | $4.78M | Buy |
|
|||||
|
2016
Q4 | $1.74M | Sell |
|
|||||
|
2016
Q3 | $4.21M | Buy |
|
|||||
|
2016
Q2 | $11K | Sell |
|
|||||
|
2016
Q1 | $96K | Buy |
|
|||||
|
2015
Q4 | $176K | Buy |
|
|||||
|
2015
Q1 | – | Hold |
|
|||||
|
2014
Q4 | – | Hold |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $801K | Sell |
|
|||||
|
2013
Q2 | $986K | Buy |
|